We therefore sought to determine whether expansion of intratumoral CD103+ DCs by local delivery of the FL growth factor36 would enhance the therapeutic efficacy of the combined treatment by promoting tumor antigen presentation and priming T cells following virotherapy-mediated ICD.35 This evidence concerns the gene ITGAE and neoplasm.